Li Tongguan, Yao Mengjiao, Hou Yanfeng
The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong Province, China.
Department of Rheumatology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong Province, China.
Medicine (Baltimore). 2025 Jul 18;104(29):e43320. doi: 10.1097/MD.0000000000043320.
Castleman disease (CD) is a rare lymphoproliferative disorder characterized by nonmalignant lymph node enlargement, often associated with systemic symptoms. It is classified into unicentric disease (involving a single enlarged lymph node) and multicentric disease (affecting multiple lymph node stations). In some cases of idiopathic multicentric Castleman disease (iMCD), elevated levels of various serum inflammatory markers are observed, and histologically, the lymph node enlargement resembles that caused by autoimmune diseases, making diagnosis challenging.
A 35-year-old female patient presented with fatigue, low-grade fever, shoulder erythema, and generalized lymphadenopathy for 2 years. Persistent systemic inflammation, anemia, thrombocytosis, hypoalbuminemia, and hyperglobulinemia were noted.
Blood tests revealed systemic inflammation, including elevated levels of C-reactive protein and interleukin-6, along with increased rheumatoid factor levels. Computed tomography scans showed a large, well-defined mass with uniform enhancement in the left neck. Skin erythema pathology was suggestive of allergic purpura. Bone marrow biopsy showed increased plasma cells. Lymph node pathology revealed an increase in IgG4-positive cells, with a high number of CD38 and CD138 plasma cells, and the morphology was consistent with Castleman disease (plasmacytic type). The diagnosis was iMCD.
Intravenous tocilizumab (400 mg every 4 weeks), methylprednisolone (40 mg daily), and oral thalidomide (75 mg daily) were administered. Symptomatic treatment included intravenous albumin (10 g daily), topical application of denaseide cream (0.5 g twice daily) for rash and pruritus, oral cetirizine (10 mg daily), and oral ebastine (10 mg daily).
The patient no longer experienced low-grade fever or fatigue but continued to have lymphadenopathy and shoulder erythema.
This case highlights the rarity and uniqueness of iMCD, which can easily be confused with lymphadenopathy caused by autoimmune diseases (e.g., rheumatoid arthritis-related lymphadenopathy, IgG4-related diseases). Clinicians should consider lymph node histology in conjunction with clinical and serological findings, as well as imaging results, for accurate diagnosis.
卡斯特曼病(CD)是一种罕见的淋巴增生性疾病,其特征为非恶性淋巴结肿大,常伴有全身症状。它分为单中心型疾病(累及单个肿大淋巴结)和多中心型疾病(影响多个淋巴结部位)。在某些特发性多中心卡斯特曼病(iMCD)病例中,可观察到各种血清炎症标志物水平升高,并且在组织学上,淋巴结肿大类似于自身免疫性疾病所致,这使得诊断具有挑战性。
一名35岁女性患者出现疲劳、低热、肩部红斑和全身淋巴结肿大2年。发现有持续性全身炎症、贫血、血小板增多、低白蛋白血症和高球蛋白血症。
血液检查显示存在全身炎症,包括C反应蛋白和白细胞介素-6水平升高,以及类风湿因子水平升高。计算机断层扫描显示左颈部有一个边界清晰的大肿块,强化均匀。皮肤红斑病理提示过敏性紫癜。骨髓活检显示浆细胞增多。淋巴结病理显示IgG4阳性细胞增多,有大量CD38和CD138浆细胞,形态符合卡斯特曼病(浆细胞型)。诊断为iMCD。
给予静脉注射托珠单抗(每4周400毫克)、甲泼尼龙(每日40毫克)和口服沙利度胺(每日75毫克)。对症治疗包括静脉注射白蛋白(每日10克)、局部涂抹地奈德乳膏(0.5克,每日两次)治疗皮疹和瘙痒、口服西替利嗪(每日10毫克)和口服依巴斯汀(每日10毫克)。
患者不再经历低热或疲劳,但仍有淋巴结肿大和肩部红斑。
本病例突出了iMCD的罕见性和独特性,它很容易与自身免疫性疾病(如类风湿关节炎相关淋巴结病、IgG4相关疾病)引起的淋巴结病相混淆。临床医生应结合临床和血清学检查结果以及影像学结果考虑淋巴结组织学,以进行准确诊断。